Results 291 to 300 of about 1,196,134 (401)

Every sheriff needs a deputy: Targeting non-parenchymal cells to treat hepatic fibrosis [PDF]

Brett M. McGettigan, Vijay H. Shah
openalex   +1 more source

Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway*

Journal of Biological Chemistry, 2017
Liu‐Ya Tang, M. Heller, Z. Meng, Li-Rong Yu, Yi Tang, Ming Zhou, Ying E. Zhang   +6 more
semanticscholar   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Safety and Effectiveness of Muse Cell Transplantation in a Large-Animal Model of Hepatic Fibrosis. [PDF]

Stem Cells Int
Nishina T, Haga H, Wakao S, Maki K, Mizuno K, Katsumi T, Hoshikawa KT, Saito T, Iseki M, Unno M, Dezawa M, Ueno Y.   +11 more
europepmc   +1 more source

Congenital Hepatic Fibrosis [PDF]

, 2020
openaire   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Pantothenic acid ameliorates hepatic fibrosis by targeting IGFBP6 to regulate the TGF-β/SMADs pathway. [PDF]

Commun Biol
Jin Z, Jin Z, Liu Z, Yin Y, Zhang Y, Zhang Y, Kang J, Fang Y, Jiang W, Ning B.   +9 more
europepmc   +1 more source

Anti-hepatic fibrosis effects of a novel turtle shell decoction by inhibiting hepatic stellate cell proliferation and blocking TGF-β1/Smad signaling pathway in rats

, 2016
Ganping Bai, Guohe Yan, Guojian Wang, Ping Wan, Ronghua Zhang   +4 more
openalex   +2 more sources

Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel

Abdominal Radiology, 2017
J. Horowitz, S. Venkatesh, R. Ehman, K. Jhaveri, P. Kamath, Michael A. Ohliger, A. Samir, Alvin C. Silva, B. Taouli, M. Torbenson, Michael L. Wells, B. Yeh, F. Miller   +12 more
semanticscholar   +1 more source